Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
bupropion hydrochloride
|
| gptkbp:approvalYear |
2011
|
| gptkbp:ATCCode |
N06AX12
|
| gptkbp:cannotBeCrushed |
true
|
| gptkbp:cannotBeSplit |
true
|
| gptkbp:contraindication |
eating disorders
seizure disorder abrupt discontinuation of alcohol |
| gptkbp:form |
extended-release tablet
450 mg |
| gptkbp:genericName |
gptkb:bupropion
|
| https://www.w3.org/2000/01/rdf-schema#label |
Forfivo XL
|
| gptkbp:indication |
gptkb:major_depressive_disorder
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
Almatica Pharma
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:mechanismOfAction |
norepinephrine reuptake inhibitor
|
| gptkbp:onceDaily |
true
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
approved
|
| gptkbp:riskFactor |
hypertension
seizures |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache insomnia dry mouth increased sweating |
| gptkbp:bfsParent |
gptkb:Wellbutrin_XL
gptkb:Wellbutrin gptkb:Zyban |
| gptkbp:bfsLayer |
7
|